Management of the N3 neck

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 11, Issue 2, 2003, Pages 129-133

  Pitman, Karen T ^a   Bradley, Patrick J ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER SURGERY; CAROTID ARTERY; CLINICAL EXAMINATION; HUMAN; NECK DISSECTION; NECK METASTASIS; ORGAN PRESERVATION; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TREATMENT PLANNING;

BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; MALE; NEOPLASM STAGING; PALLIATIVE CARE; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 0037378831     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200304000-00012     Document Type: Review

References (29)

1. Stell PM, Green JR: Management of metastases to the lymph glands of the neck. Proc R Soc Med 1976, 69:411-413.
2. Mendenhall WM, Mancuso AA, Amdur RJ, et al.: Squamous cell carcinoma metastasis to the neck from an unknown primary site. Am J Otolaryngol 2001, 22:261-267.
3. American Joint Committee on Cancer: Cancer Staging Manual, edn. 5. Philadelphia: JB Lippincott 1997.
4. Spiro RH, Alfonso AE, Hollon WF, et al.: Cervical node metastases from squamous cell carcinoma of the oral cavity and oropharynx. Am J Surg 1974, 128:562-567.
5. Stell PM: Fixed, bilateral cervical nodes. J Laryngol Otol 1983, 97:851-856.
6. Van den Brekel MW, Castelijns JA: Radiologic evaluation of neck metastases: the otolaryngologist's perspective. Semin Ultrasound CT MR 1999, 20:162-174.
7. Yousem DM, Hatabu H, Hurst RW, et al.: Carotid artery invasion by head neck masses: prediction with MR imaging. Radiology 1995, 195:715-720.
8. Yoo GH, Howald E, Korkmaz H, et al.: Assessment of carotid artery invasion in patients with head and neck cancer. Laryngoscope 2000, 110:386-390.
9. Mann WJ, Beck A, Schreiber J, et al.: Ultrasound for evaluation of the carotid artery in head neck cancer. Laryngoscope 1994, 104:885-888.
10. Netterville JL, Civantos FJ: N3 neck: optimal therapy. In The Neck: Diagnosis and Surgery. Edited by Shockley WW, Pilsbury HC. St. Louis: Mosby Year Book; 1993:405-411.
11. Robbins KT, Atkinson JLD, Byers RM, et al.: The use and misuse of neck dissection for head neck cancer. J Am Coll Surg 2001, 193:91-102.
12. Muhm M, Grasl M CH, Burian M, et al.: Carotid resection and reconstruction for locally advanced head neck tumors. Acta Otolaryngol 2002, 122:561-564.
13. Gavilan J, Ferlito A, Silver, et al.: Status of carotid resection in head neck cancer. Acta Otolaryngol 2002, 122:453-455. The authors review current management options for patients with carotid invasion.
14. Stell PM: Survival times in end-stage head neck cancer. Eur J Surg Oncol 1989, 15:407-410.
15. Picarillo JF: Inclusion of comorbidity in a staging system for head neck cancer. Oncology 1995, 9:831-845.
16. Loevner LA, Ott IL, Yousem DM, et al.: Neoplastic fixation to the prevertebral compartment by squamous cell carcinoma of the head and neck. AJR Am J Roentgenol 1998, 170:1389-1394.
17. Richards BL, Spiro JD: Controlling advanced neck disease: efficacy of neck dissection and radiotherapy. Laryngoscope 2000, 110:1124-1127.
18. Ferlito A, Sliver CE, et al.: Management of the N3 neck. Acta Otolaryngol 2002, 122:230-233. A comprehensive overview of contemporary management issues.
19. Freeman SB, Hamaker RC, Rate WR, et al.: Management of advanced cervical metastasis using intraoperative radiotherapy. Laryngoscope 1995, 105:575-578.
20. Davis RK, Straight R, Sun Y: Intraoperative phototherapy: a comparative study of intravenous and topical photofrin II and aminolevulinic acid. Otolaryngol Head Neck Surg 1997, 116:223-227.
21. Biel MA: Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head neck carcinomas. J Clin Laser Med Surg 1996, 14:838-847.
22. Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991, 324:1685-1690.
23. Robbins KT, Wong FSH, Kumar P, et al.: Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head neck cancer. Arch Otolaryngol Head Neck Surg 1999, 125:670-675.
24. Weisman RA, Christen RD, Jones VE, et al.: Observations on control of N2 and N3 neck disease in squamous cell carcinoma of the head neck by intra-arterial chemoradiation. Laryngoscope 1998, 108:800-805.
25. Johansen J, Eigtved A, Buchwald C, et al.: Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on the management of carcinoma of unknown primary in the head neck: a Danish cohort study. Laryngoscope 2002, 112:2009-2014.
26. Stenson KM, Haraf DJ, Pelzer H, et al.: The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000, 126:950-956. The authors present results of neck dissection for patients who had complete clinical response following cytoreductive treatment.
27. Wang SJ, Wang MB, Yip H, et al.: Combined radiotherapy with planned neck dissection for small head neck cancers with advanced cervical metastases. Laryngoscope, 2000, 110:1794-1797. Findings are similar to [26], and together, these two studies provide data to suggest the treatment plan for with advanced regional disease include interval neck dissection.
28. Abdelkarim AS, Dulguerov P, Bieri S, et al.: A conservation approach to pharyngeal carcinoma with advanced neck disease: optimizing neck management. Head Neck 1999, 21:217-222.
29. Strasser MD, Gleich LL, Miller MA, et al.: Management implications of evaluating the N2 and N3 neck after organ preservation therapy. Laryngoscope 1999, 109:1776-1780.